Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Cannabis Bioscience International Holdings (CBIH) Equity Ratio (2023 - 2025)

Cannabis Bioscience International Holdings' Equity Ratio history spans 3 years, with the latest figure at 61.6 for Q4 2025.

  • For Q4 2025, Equity Ratio fell 88.7% year-over-year to 61.6; the TTM value through Nov 2025 reached 61.6, down 88.7%, while the annual FY2025 figure was 36.5, 93.36% down from the prior year.
  • Equity Ratio for Q4 2025 was 61.6 at Cannabis Bioscience International Holdings, up from 65.79 in the prior quarter.
  • Across five years, Equity Ratio topped out at 8.27 in Q4 2023 and bottomed at 82.33 in Q1 2025.
  • The 3-year median for Equity Ratio is 27.72 (2024), against an average of 35.28.
  • The largest annual shift saw Equity Ratio plummeted 38.41% in 2024 before it tumbled 692.66% in 2025.
  • A 3-year view of Equity Ratio shows it stood at 8.27 in 2023, then tumbled by 294.87% to 32.64 in 2024, then tumbled by 88.7% to 61.6 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's Equity Ratio are 61.6 (Q4 2025), 65.79 (Q3 2025), and 36.5 (Q2 2025).